What Researchers Did
Researchers compared conventional treatment, including hyperbaric oxygen therapy, with the addition of Ginaton for 116 patients experiencing delayed brain damage after carbon monoxide poisoning over two weeks.
What They Found
The group receiving Ginaton in addition to conventional treatment showed a significantly higher overall response rate (81.03%) compared to the conventional treatment-only group (62.07%). After two weeks, the Ginaton group also experienced significantly greater reductions in blood markers like NO, NSE, NOS, and iNOS, which are associated with brain injury.
What This Means for Canadian Patients
This study suggests that Ginaton, when used alongside conventional treatments including hyperbaric oxygen therapy, could potentially improve recovery for Canadian patients suffering from delayed encephalopathy after carbon monoxide poisoning. Exploring such adjunctive therapies might offer enhanced outcomes beyond current standard care for this serious condition.
Canadian Relevance
This study covers carbon monoxide poisoning, which is a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
The abstract does not provide specific details on the hyperbaric oxygen therapy protocol used, and the study focuses on an adjunctive therapy rather than HBOT as the primary intervention.